Le Lézard
Classified in: Health, Science and technology
Subjects: SVY, TRI, FVT

Late-Breaking Abstract Submissions Are Now Open for the 15th Annual WORLDSymposium 2019 Research Conference in Orlando, Florida, USA


ORLANDO, Fla., Nov. 12, 2018 /PRNewswire/ -- There are less than 12 weeks until the 15th Annual WORLDSymposium 2019 Research Congress dedicated to lysosomal diseases. The annual research meeting, taking place 4th ? 8th February 2019 in Orlando, Florida, is now accepting late-breaking abstract submissions for poster presentation only. 

We're Organizing Research on Lysosomal Diseases -- Please join us at the 15th Annual WORLDSymposium February 4 - 8, 2019 in Orlando, Florida.

WORLDSymposium is the premier international scientific meeting focused on lysosomal diseases - researchers from over 50 countries attend. The cutting-edge research presented at WORLDSymposium gains worldwide attention. 

More information about late-breaking abstracts is available on the WORLDSymposium website. The late-breaking abstract submission deadline is December 1, 2018.

With the congress less than 12 weeks away and hotel room reservations becoming increasingly limited, potential attendees are urged to register soon to avoid missing out. Key reasons to attend this exceptional conference on lysosomal diseases include:

The program for WORLDSymposium 2019 will be posted by the end of November 2018. 

To submit a late-breaking abstract or to register for WORLDSymposium 2019 visit: https://www.worldsymposia.org

About WORLDSymposium: Since its inception as a small group of passionate researchers in 2002, WORLDSymposium has grown to an international research conference that attracts over 1800 participants from more than 50 countries around the globe. WORLDSymposium is now considered the premier international forum for gathering experts from around the globe who are actively involved in Basic Science, Translational Studies, and Clinical Applications for lysosomal diseases.  More information can be found at https://www.worldsymposia.org

email: [email protected]

 

SOURCE WORLDSymposium


These press releases may also interest you

at 07:05
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...

at 07:00
César A. Lara, MD, introduces a groundbreaking solution for pain relief in the Tampa Bay area. Red Laser Therapy leverages the power of medical-grade red laser light to effectively address various types of pain, providing patients with a noninvasive...



News published on and distributed by: